Interleukin 19: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 19: | Line 19: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:A_demonstration_of_IL-19_binds_to_IL20_Receptor_on_the_surface_of_immune_cells_to_regulate_cytokines_expression.png|A demonstration of IL-19 binds to IL20 Receptor on the surface of immune cells to regulate cytokines expression | |||
File:The_anti-inflammatory_effect_of_IL-19_in_vascular_diseases.png|The anti-inflammatory effect of IL-19 in vascular diseases | |||
</gallery> | |||
Latest revision as of 01:27, 18 February 2025
Interleukin 19 (IL-19) is a protein that in humans is encoded by the IL19 gene. It is a member of the interleukin family of cytokines, which are proteins involved in cell signaling and immune responses.
Function[edit]
IL-19 is produced by monocytes and B cells and acts on keratinocytes and monocytes. It is involved in inflammatory responses and the regulation of cell growth. IL-19 has been shown to stimulate the production of other cytokines, including interleukin 6 and tumor necrosis factor alpha, and to induce the expression of intercellular adhesion molecule-1.
Clinical significance[edit]
IL-19 has been implicated in a number of diseases, including rheumatoid arthritis, psoriasis, and asthma. It has also been suggested that it may play a role in the development of atherosclerosis.
References[edit]
<references />
External links[edit]
- IL19 at the US National Library of Medicine Medical Subject Headings (MeSH)


